Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-09-21 Purchase |
2020-09-23 7:11 pm |
Dyne Therapeutics Inc. | DYN | VV Manager II LLC Vida Ventures II LLC VIDA VENTURES II-A LLC 10% Owner |
815,000 | $19 | $15,485,000 | 79,921 (Indirect) |
View |
| 2020-09-21 Purchase |
2020-09-23 7:09 pm |
Dyne Therapeutics Inc. | DYN | Logos Global Management LP 10% Owner |
700,000 | $19 | $13,300,000 | 1,504,392 (Indirect) |
View |
| 2020-09-21 Purchase |
2020-09-23 6:55 pm |
Dyne Therapeutics Inc. | DYN | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
660,000 | $19 | $12,540,000 | 2,805,045 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-09-21 Conversion |
2020-09-23 7:12 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | MPM BIOVENTURES 2018 L.P. MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC MPM BioVentures 2018 GP LLC MPM BioVentures 2018 LLC EVNIN LUKE Foley Todd GADICKE ANSBERT 10% Owner |
21,374,284 | $0 | 91,081 (Indirect) |
View |
| 2020-09-21 Conversion |
2020-09-23 7:11 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | VV Manager II LLC Vida Ventures II LLC VIDA VENTURES II-A LLC 10% Owner |
9,259,951 | $0 | 79,921 (Indirect) |
View |
| 2020-09-21 Conversion |
2020-09-23 7:10 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Lubner David Charles Director |
231,497 | $0 | 257,097 (Direct) |
View |
| 2020-07-31 Option Award |
2020-09-23 7:10 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Lubner David Charles Director |
25,600 | $0 | 257,097 (Direct) |
View |
| 2020-09-21 Conversion |
2020-09-23 7:09 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Logos Global Management LP 10% Owner |
3,472,481 | $0 | 1,504,392 (Indirect) |
View |
| 2020-09-21 Conversion |
2020-09-23 7:06 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Forbion Capital Fund IV Cooperatief U.A. 10% Owner |
26,467,258 | $0 | 6,131,079 (Direct) |
View |
| 2020-09-21 Conversion |
2020-09-23 7:05 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | CureDuchenne Ventures LLC 10% Owner |
2,602,972 | $0 | 602,972 (Direct) |
View |
| 2020-09-21 Conversion |
2020-09-23 7:04 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director |
46,299 | $0 | 71,899 (Direct) |
View |
| 2020-07-31 Option Award |
2020-09-23 7:04 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director |
25,600 | $0 | 71,899 (Direct) |
View |
| 2020-09-21 Conversion |
2020-09-23 7:03 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
46,299 | $0 | 176,887 (Direct) |
View |
| 2020-07-31 Option Award |
2020-09-23 7:03 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
25,600 | $0 | 176,887 (Direct) |
View |
| 2020-09-21 Conversion |
2020-09-23 7:00 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
32,974,690 | $0 | 1,608,785 (Indirect) |
View |
| 2020-09-21 Conversion |
2020-09-23 6:59 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director 10% Owner |
26,467,258 | $0 | 26,467,258 (Indirect) |
View |
| 2020-09-21 Conversion |
2020-09-23 6:56 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
6,944,964 | $0 | 1,608,785 (Direct) |
View |
| 2020-09-21 Conversion |
2020-09-23 6:56 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
32,974,690 | $0 | 1,608,785 (Indirect) |
View |
| 2020-09-21 Conversion |
2020-09-23 6:55 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
9,259,950 | $0 | 2,805,045 (Indirect) |
View |
| 2020-09-21 Conversion |
2020-09-23 6:55 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | HURWITZ EDWARD Director 10% Owner |
21,374,284 | $0 | 16,514,062 (Indirect) |
View |
| 2020-09-16 Option Award |
2020-09-18 5:16 pm |
N/A 2030-09-15 |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
147,309 | $0 | 147,309 (Direct) |
View |
| 2020-09-16 Option Award |
2020-09-18 5:13 pm |
N/A 2030-09-15 |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana See Remarks |
79,146 | $0 | 79,146 (Direct) |
View |
| 2020-09-16 Option Award |
2020-09-18 5:12 pm |
N/A 2030-09-15 |
Dyne Therapeutics Inc. | DYN | Subramanian Romesh Chief Scientific Officer 10% Owner |
169,494 | $0 | 694,434 (Direct) |
View |
| 2020-09-16 Option Award |
2020-09-18 5:11 pm |
N/A 2030-09-15 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
69,799 | $0 | 89,697 (Direct) |
View |
| 2020-09-16 Option Award |
2020-09-18 5:11 pm |
N/A 2030-09-15 |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
427,808 | $0 | 427,808 (Direct) |
View |
| 2020-09-16 Option Award |
2020-09-18 5:10 pm |
N/A 2030-09-15 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
47,040 | $0 | 47,040 (Direct) |
View |
Ownership |
2020-09-17 6:25 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
0 | $0 | 329,143 (Direct) |
View |
Ownership |
2020-09-16 8:54 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
0 | $0 | 174,121 (Direct) |
View |
Ownership |
2020-09-16 8:53 pm |
N/A 2030-03-18 |
Dyne Therapeutics Inc. | DYN | Lubner David Charles Director |
0 | $0 | 112,033 (Direct) |
View |
Ownership |
2020-09-16 8:52 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director 10% Owner |
0 | $0 | 6,131,079 (Indirect) |
View |
Ownership |
2020-09-16 8:51 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | HURWITZ EDWARD Director 10% Owner |
0 | $0 | 4,951,303 (Indirect) |
View |
Ownership |
2020-09-16 8:51 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
0 | $0 | 2,145,045 (Indirect) |
View |
Ownership |
2020-09-16 8:50 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
0 | $0 | 1,608,785 (Direct) |
View |
Ownership |
2020-09-16 8:49 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | MPM BIOVENTURES 2018 L.P. MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC MPM BioVentures 2018 GP LLC MPM BioVentures 2018 LLC EVNIN LUKE Foley Todd GADICKE ANSBERT 10% Owner |
0 | $0 | 4,951,303 (Indirect) |
View |
Ownership |
2020-09-16 8:48 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director 10% Owner |
0 | $0 | 9,748,915 (Indirect) |
View |
Ownership |
2020-09-16 8:47 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Logos Global Management LP 10% Owner |
0 | $0 | 804,392 (Indirect) |
View |
Ownership |
2020-09-16 8:46 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
0 | $0 | 1,244,930 (Direct) |
View |
Ownership |
2020-09-16 8:45 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
0 | $0 | 196,894 (Direct) |
View |
Ownership |
2020-09-16 8:44 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Forbion Capital Fund IV Cooperatief U.A. 10% Owner |
0 | $0 | 6,131,079 (Direct) |
View |
Ownership |
2020-09-16 8:44 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | CureDuchenne Ventures LLC 10% Owner |
0 | $0 | 602,972 (Direct) |
View |
Ownership |
2020-09-16 8:43 pm |
N/A 2029-09-05 |
Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director |
0 | $0 | 69,133 (Direct) |
View |
Ownership |
2020-09-16 8:40 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | VV Manager II LLC Vida Ventures II LLC VIDA VENTURES II-A LLC 10% Owner |
0 | $0 | 2,145,046 (Indirect) |
View |
Ownership |
2020-09-16 8:39 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
0 | $0 | 157,514 (Direct) |
View |
Ownership |
2020-09-16 8:39 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Atlas Venture Fund XI L.P. Atlas Venture Associates XI LLC Atlas Venture Associates XI L.P. Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
0 | $0 | 9,748,915 (Indirect) |
View |
Ownership |
2020-09-16 8:39 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana See Remarks |
0 | $0 | 189,873 (Direct) |
View |